{"cluster": 22, "subcluster": 14, "abstract_summ": "Importance: Reported cases of SARS-CoV-2 infection likely underestimate the prevalence of infection in affected communities.Objective: To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the United States.Conclusions and relevance: Our seroprevalence estimates suggest that for five of six U.S. sites, from late March to early May 2020, >10 times more SARS-CoV-2 infections occurred than the number of reported cases.Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic.Population-based serosurveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies provide one method for estimating infection rates and monitoring the progression of the epidemic.", "title_summ": "Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, SwitzerlandSeroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreakSeroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, BrazilSeroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study", "title_abstract_phrases": "Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020Importance: Reported cases of SARS-CoV-2 infection likely underestimate the prevalence of infection in affected communities.Tracking population seroprevalence serially, in a variety of specific geographic sites, will inform models of transmission dynamics and guide future community-wide public health measures.Conclusions and relevance: Our seroprevalence estimates suggest that for five of six U.S. sites, from late March to early May 2020, >10 times more SARS-CoV-2 infections occurred than the number of reported cases.Objective: To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the United States.Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, SwitzerlandBackground: Assessing the burden of COVID-19 based on medically-attended case counts is suboptimal given its reliance on testing strategy, changing case definitions and the wide spectrum of disease presentation."}